Amgen (AMGN) Invested Capital (2009 - 2026)

Amgen's Invested Capital history runs 18 years deep, the most recent figure standing at $66.5 billion for Q1 2026.

• In Q1 2026, Invested Capital rose 4.6% year-over-year to $66.5 billion; the TTM figure through Mar 2026 stood at $66.5 billion (up 4.6% YoY), while the FY2025 annual figure was $63.3 billion, down 4.11% from the prior year.
• Invested Capital was $66.5 billion for Q1 2026 at Amgen, up from $63.3 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $70.8 billion in Q4 2023 to a low of $37.8 billion in Q1 2022.
• Historically, Invested Capital has averaged $60.5 billion across 5 years, with a median of $66.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2023: Invested Capital fell 10.03% in 2022, then soared 77.04% in 2023.
• A 5-year view of Invested Capital shows it stood at $42.6 billion in 2022, then jumped by 66.46% to $70.8 billion in 2023, then decreased by 6.87% to $66.0 billion in 2024, then decreased by 4.11% to $63.3 billion in 2025, then rose by 5.14% to $66.5 billion in 2026.
• The last three Invested Capital figures came in at $66.5 billion (Q1 2026), $63.3 billion (Q4 2025), and $64.2 billion (Q3 2025), per Business Quant data.